SCHEMBL24207461

SCHEMBL24207461

CCc1c(N)ccc2nc(Cl)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
KDM4E B2RXH2 3/20 0.36
CYP3A4 P08684 1/20 0.36
HIF1A Q16665 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
IDO1 P14902 1/20 0.35
ALDH1A1 P00352 3/20 0.33
NR4A2 P43354 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TLR7 Q9NYK1 1/20 0.31
MEN1 O00255 1/20 0.31
TERT O14746 1/20 0.31
ABCB11 O95342 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3346154 0.81 KDM4E (0.42) CYP2C19CYP1A2CYP2D6CYP2C9RXFP1
SCHEMBL22951342 0.77 NR4A2 (0.40) CYP2C19KDM4ECYP3A4HIF1AIDO1
SCHEMBL24207416 0.76 IDO1 (0.35) CYP2C19KDM4ECYP3A4HIF1AIDO1
SCHEMBL25083068 0.73 IMPDH2 (0.42) CYP2C19CYP1A2KDM4ECYP3A4HIF1A
SCHEMBL22951353 0.73 IDO1 (0.38) CYP2C19CYP1A2KDM4ECYP3A4HIF1A
SCHEMBL24743148 0.71 IDO1 (0.34) CYP2C19CYP1A2KDM4ECYP3A4HIF1A
SCHEMBL1464159 0.70 MAPT (0.59) CYP1A2KDM4ECYP3A4HIF1AIDO1
SCHEMBL22950952 0.70 IDO1 (0.33) CYP2C19CYP1A2KDM4ECYP3A4HIF1A
SCHEMBL1474541 0.70 DHFR (0.40) CYP1A2CYP2D6CYP2C9KDM4ECYP3A4
SCHEMBL29364256 0.70 DHFR (0.40) CYP1A2CYP2D6CYP2C9KDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022012622-A1 DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2022-01-20 WO disclosed